Pasireotide in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors

Clinical trial NCT00804336 · COMPLETED

Trial details

NCT number: NCT00804336
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Neuroendocrine Tumor Carcinoid Tumor Pancreatic Neuroendocrine Tumor

Start date: 2008-10-01
Primary completion: 2014-09-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.